Article Abstract

Stereotactic radiofrequency ablation for hepatocellular carcinoma

Authors: Andrea Mancuso

Abstract

Hepatocellular carcinoma (HCC) is the number 2 most common cause of death from cancer worldwide and overall a major global health problem. Moreover, albeit the incidence of HCC goes up gradually with advancing age, reaching a peak at 70 years, globally there is an increasing incidence of HCC worldwide (1).